Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Comment by dt_coreon Jan 19, 2024 9:21am
105 Views
Post# 35835580

RE:Never ending drip

RE:Never ending drip Late Friday unfavourable news releass always signals that management is trying to sneak one past investors. All it ever ends up doing is shake investor confidence so yes I'm happy that they announced mid-week, though I didn't see an official press release in my inbox this morning.

I was quite certain that they needed to draw the entire $5M they prenegotiated with Beedie after a weak Q3 and what they signalled as only a partial recovery in Q4. In total now THNK is paying just under $6M in interest and while some of that is PIK rather than cash payments its still a lot for a company that is just turning EBITDA positive. Assuming that they need to fund about $3 million in capex/intangibles plus $1.7M in upcoming short term obligations (not incl. Scotia debt) and you have a company that will only breakeven cash flow wise if they hit close to $11 million in Adj. EBITDA (Analysts are forecasting $6.7 million in Adj. EBITDA for 2024 and $10 million in 2025). With all the Beedie line draws cash on hand should be around $8 million at present. So for 2025 they have a cash shortfall of about $5M and the following year closer to break even. The wild card here is THNK landing a big deal (or deals) in their self proclaimed "mature pipeline" but news on that front has been very lite which is inconsistent with managements rhetoric during conference calls. 

So where do we go from here? I'f I'm Beedie and also Scotia I'm looking for a private equity sponsor or large strategic buyer to aquire the company. For Beedie a price of $0.50 to $0.60 would do it so that they can realize a good return on their convertibles which would auto convert on a takeover. A takeover would allow Scotia to exit its debt position. 
<< Previous
Bullboard Posts
Next >>